Scientists Accuse Government of Dishonesty Over GM Babies in its Regulation of new IVF Technique
By Steve Connor,
The Independent
| 07. 28. 2014
Untitled Document
The Government has been accused of misleading the public over the introduction of a new in vitro fertilisation (IVF) technique that some experts believe will result in the birth of “genetically modified babies”.
Leading scientists, including Lord Winston, an early pioneer of fertility treatment, have criticised the Department of Health for trying to play down a process that will for the first time allow the alteration of the DNA of future generations.
They argue that the Government has redefined the term “genetic modification” (GM) to exclude specifically a controversial technique that will result in babies inheriting genetic material from three individuals.
The move, buried within a Department of Health document published last week, is designed to take the sting out of hostility towards mitochondrial donation – a process that aims to avoid the certain inherited diseases being passed on by using healthy mitochondria (microscopic structures in the cell) taken from a donor egg or embryo. Opponents believe that using the healthy donor mitochondria will result in “three-parent embryos” and could usher in an era of “designer babies”...
Related Articles
Not the species, certainly, but the Institute of that name, which was founded by transhumanist philosopher Nick Bostrom in 2005 as a research group at Oxford University. According to a recently posted Final Report, its goal was “to pursue the big questions in a transdisciplinary way” by pulling together “researchers from disciplines such as philosophy, computer science, mathematics, and economics.” This evolved before long into the study and promotion of “effective altruism” and “longtermism” as...
By Yelena Biberman and Jonathan D. Moreno, Bioethics Forum | 04.16.2024
A quiet biological revolution in warfare is underway. The genome is emerging as a new domain of conflict. The level of destruction that only nuclear weapons could previously achieve is fast becoming as accessible as a cyberattack.
Now for the...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...